©The Author(s) 2025.
World J Psychiatry. Nov 19, 2025; 15(11): 112431
Published online Nov 19, 2025. doi: 10.5498/wjp.v15.i11.112431
Published online Nov 19, 2025. doi: 10.5498/wjp.v15.i11.112431
Table 3 Comparison of Calgary depression scale for schizophrenia scores between experimental and control groups
| Outcome | Experimental group (n = 34) | Control group (n = 34) | MD (95%CI) | P value | Cohen’s d1 |
| Baseline | 12.32 ± 2.67 | 12.12 ± 2.90 | 0.21 (-1.14, 1.56) | 0.762 | - |
| 2-week follow up | 10.15 ± 2.73 | 10.91 ± 2.09 | -0.76 (-1.94, 0.41) | 0.200 | - |
| 4-week follow up | 8.32 ± 1.84 | 9.65 ± 1.72 | -1.32 (-2.19, -0.46) | 0.003 | 0.74 |
| 8-week follow up | 6.88 ± 1.43 | 8.41 ± 1.35 | -1.53 (-2.20, -0.86) | < 0.001 | 1.10 |
| 12-week follow up | 4.00 ± 2.10 | 5.68 ± 1.70 | -1.68 (-2.60, -0.75) | < 0.001 | 0.88 |
- Citation: Huang RC, Wareesawetsuwan N, Lin N, Li XD. Computerized cognitive behavioral therapy with sertraline in schizophrenia with depressive episodes: A 12-week randomized controlled trial. World J Psychiatry 2025; 15(11): 112431
- URL: https://www.wjgnet.com/2220-3206/full/v15/i11/112431.htm
- DOI: https://dx.doi.org/10.5498/wjp.v15.i11.112431